Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.

Area of Science:

• Microbiology
• Pharmacology
• Gastroenterology

Background:

• Antibiotic treatment for Clostridium difficile-associated diarrhea (CDAD) can disrupt gut microbiota, potentially leading to vancomycin-resistant enterococci (VRE) colonization.
• Cadazolid (CDZ) is an investigational antibiotic with demonstrated in vitro activity against both C. difficile and VRE.

Purpose of the Study:

• To evaluate the effect of Cadazolid (CDZ) treatment on intestinal VRE colonization in a preclinical model.

Main Methods:

• A mouse model was used to assess the impact of CDZ treatment on VRE colonization.
• Mice were treated with CDZ, and intestinal VRE levels were monitored.

Main Results:

• CDZ treatment did not result in the overgrowth of VRE in the intestines of the treated mice.
• This suggests that CDZ does not promote VRE colonization.

Conclusions:

• Cadazolid (CDZ) may be a safe treatment option for CDAD, as it does not appear to induce VRE overgrowth.
• Further clinical studies are warranted to confirm these findings in human patients.